OQS
XGN icon

Occudo Quantitative Strategies’s Exagen XGN Stock Holding History

Occudo Quantitative Strategies’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.9K Sell
20,632
-7,202
-26% -$27.1K 0.01% 732
2026
Q1 		$80.7K Sell
27,834
-2,380
-8% -$9.21K ﹤0.01% 717
2025
Q4 		$184K Buy
30,214
+9,346
+45% +$85.1K 0.01% 608
2025
Q3 		$229K Buy
20,868
+1,060
+5% +$9.39K 0.03% 555
2025
Q2 		$138K Buy
+19,808
New +$120K 0.02% 558

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Occudo Quantitative Strategies's XGN Position: Q2 2026 in Review

Occudo Quantitative Strategies reduced its Exagen (XGN) stake by 26% in Q2 2026, selling an estimated $27.1K and leaving 20,632 shares worth $95.9K. The position accounts for 0.01% of the portfolio, ranked #732.

Occudo Quantitative Strategies first reported a position in XGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $229K in Q3 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Occudo Quantitative Strategies held 20,632 shares of Exagen worth $95.9K as of Q2 2026.
  • Occudo Quantitative Strategies sold 7,202 Exagen shares in Q2 2026, an estimated $27.1K.
  • Exagen made up 0.01% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #732 holding.
  • Occudo Quantitative Strategies first reported a position in Exagen in Q2 2025 and has held it in 5 quarters since.
  • Occudo Quantitative Strategies's Exagen position peaked at $229K in Q3 2025.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.